Bone loss medicines linked to lower ovarian cancer rates
Medicines used to prevent bone loss may help lower the risk of ovarian cancer according to research by The University of Queensland.
Jun 17, 2022
0
5
Medicines used to prevent bone loss may help lower the risk of ovarian cancer according to research by The University of Queensland.
Jun 17, 2022
0
5
Epithelial ovarian cancer (EOC) exhibits strong dependency on the tricarboxylic acid (TCA) cycle and oxidative phosphorylation to fuel anabolic process. S-palmitoylation refers to the addition of the saturated 16-carbon fatty ...
Jun 10, 2022
0
1
Inherited mutations in the BRCA1 gene can significantly increase a person's risk of breast and ovarian cancer—but not every mutation in the gene is harmful. To better equip patients and their doctors to understand and manage ...
Jun 3, 2022
0
33
Ovarian cancer has one of the highest death rates of all cancers. One reason for this is that the cancer turns the body's defenses against itself. However, new research from Nagoya University published in Matrix Biology suggests ...
May 31, 2022
0
262
The appearance of ovarian lesions on ultrasound may predict the risk for malignancy, according to a study published in the June issue of Radiology.
May 27, 2022
0
3
Initial study results show that an experimental drug, called nemvaleukin alfa, when used alone or in combination with another anticancer drug (pembrolizumab) may be effective in treating several types of late-stage cancers ...
May 26, 2022
0
20
A simple blood test that can be given by general practitioners (GPs) could help diagnose ovarian cancer faster and more accurately, particularly for women under the age of 50, according to research funded by leading women's ...
May 5, 2022
0
15
Chimeric antigen receptor T-cell therapy, or CAR T, has made a big impact on the treatment of certain blood cancers, allowing patients with relapsed/refractory disease to live longer, healthier lives. But in clinical study, ...
May 5, 2022
0
51
Vanderbilt University Research Professor of Nursing Sheila Ridner recently completed a large, randomized trial to assess early detection methods for a common side effect of breast-cancer treatments—lymphedema.
Apr 28, 2022
0
10
The protein FOXK2 promotes survival of cancer stem cells in ovarian cancer, according to a Northwestern Medicine study published in the Journal of Clinical Investigation.
Apr 27, 2022
0
38